CompanyRNAZNasdaqBoston, MA

TransCode Therapeutics

TransCode Therapeutics develops RNA therapeutics and immunotherapies for advanced cancers.

SEC EDGAR ClinicalTrials.gov

8-KSep 28Latest SEC filing

Sep 28Latest story

September 2026

TransCode reports updated Phase 1a data for TTX-MC138 in advanced solid tumors

Sep 28Clinical readoutTransCode Therapeutics